We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Regulator: Actavis, Concordia Reached Deal to Fix Prices
UK Regulator: Actavis, Concordia Reached Deal to Fix Prices
The UK’s antitrust regulator alleges that Actavis and Concordia entered a pay-for-delay agreement to block the market entry of generic versions of hydrocortisone tablets and fix prices.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor